Literature DB >> 4089052

Urinary biopterin and neopterin excretion and pituitary-adrenal activity in psychiatric patients.

J C Garbutt, D S Duch, C A Nichol, J H Woolf.   

Abstract

The urinary excretion of biopterin and neopterin, pterin compounds related to tetrahydrobiopterin, the cofactor for the initial steps in monoamine synthesis, was serially measured in a heterogeneous group of psychiatric patients and compared to excretion in control subjects, to state of illness, and to the results of the dexamethasone suppression test. Patients with major depression had increased excretion of biopterin compared to normal subjects. There was no relationship between biopterin or neopterin excretion and postdexamethasone cortisol levels. Pterin excretion did not significantly change with improvement in mood or with conversion from nonsuppressor to suppressor status. The meaning of increased urinary biopterin is presently unclear, although its relation to hormonal state and sympathoadrenal tone deserves further study.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4089052     DOI: 10.1016/0165-1781(85)90105-2

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Plasma and urinary levels of biopterin, neopterin, and related pterins and plasma levels of folate in infantile autism.

Authors:  I Eto; M D Bandy; C E Butterworth
Journal:  J Autism Dev Disord       Date:  1992-06

2.  Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder.

Authors:  Mary Ann Richardson; Laura L Read; Margaret A Reilly; James D Clelland; Catherine L Taylor Clelland
Journal:  Neurochem Res       Date:  2006-12-09       Impact factor: 3.996

Review 3.  Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms.

Authors:  Sylvie Vancassel; Lucile Capuron; Nathalie Castanon
Journal:  Front Neurosci       Date:  2018-07-24       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.